Skip to content
ClinCalc Pro
Menu
Thiazide Diuretic — Calcium Stone Prevention

Hydrochlorothiazide

Brand names: HydroSaluric

Hydrochlorothiazide is an oral thiazide diuretic; although coded here under urology, its principal uses are hypertension and oedema, and within renal/urological practice it is used to reduce urinary calcium excretion in recurrent calcium stone formers.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

It inhibits the sodium-chloride cotransporter in the distal convoluted tubule, increasing sodium and water loss while paradoxically enhancing distal calcium reabsorption, which lowers urinary calcium.

Prescribing in practice

  • It can cause clinically important electrolyte disturbance, notably hyponatraemia and hypokalaemia, so check electrolytes before starting and during treatment, particularly in the elderly.
  • Thiazides raise serum urate and can precipitate gout, and may unmask or worsen glucose intolerance.
  • Efficacy as a diuretic falls in significant renal impairment, where a loop diuretic is usually preferred.

Monitoring

Monitor urea and electrolytes (especially sodium and potassium), renal function, and where relevant urate and glucose.

Counselling the patient

  • Take in the morning to avoid night-time passing of urine.
  • Report persistent dizziness, muscle cramps, marked thirst or confusion, which may indicate salt imbalance.

Evidence & guidelines

Thiazide and thiazide-like diuretics are well established for hypertension and, per stone-prevention guidance, reduce recurrence in hypercalciuric calcium stone formers.

Reference: EAU Urolithiasis Guidelines 2024; AUA Stone Disease Guidelines 2019; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.